Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Stroke. 2008 Dec 18;40(2):505–509. doi: 10.1161/STROKEAHA.108.528281

Table 1.

Baseline features of patients ON vs. OFF antithrombotic therapy at the time of the qualifying event (QE)

Characteristic ON Antithrombotic OFF Antithrombotic p-value
Number of patients (%)
Qualifying event
 Type of event
  TIA alone 150/299 (50.2) 72/269 (26.8)
  Stroke alone 90/299 (30.1) 150/269 (55.8)
  Stroke w/prior TIA 51/299 (17.1) 39/269 (14.5)
  TIA w/prior stroke 8/299 (2.7) 8/269 (3.0) 0.0001
Days from QE to randomization± 31.2 (28.6) 28.4 (27.4) 0.2354
Demographics
 Male sex 181/299 (60.5) 169/269 (62.8) 0.5752
 Race
  Black 66/299 (22.1) 107/269 (39.8)
  White 203/299 (67.9) 128/269 (47.6)
  Other 30/299 (10.0) 34/269 (12.6) 0.0001
 Age in years± 65.3 (11.2) 61.6 (11.3) 0.0001
Past Medical History
 History of hypertension 263/299 (88.0) 213/267 (79.8) 0.0079
 History of diabetes 117/299 (39.1) 99/268 (36.9) 0.5919
 History of lipid disorder 233/294 (79.2) 157/257 (61.1) 0.0001
 History of CAD 118/294 (40.1) 33/262 (12.6) 0.0001
 History of ischemic stroke 102/293 (34.8) 35/263 (13.3) 0.0001
 Statin use 208/299 (69.6) 138/269 (51.3) 0.0001
 Diuretic use 70/299 (23.4) 62/269 (23.0) 0.9185
 ACE use 125/299 (41.8) 108/269 (40.2) 0.6885
 Smoking status
  Never 109/299 (36.4) 93/269 (34.6)
  Previously 141/299 (47.2) 104/269 (38.7)
  Currently 49/299 (16.4) 72/269 (26.8) 0.0079
Location of Stenotic artery
 ICA 65/286 (22.7) 54/264 (20.4)
 MCA 65/286 (22.7) 113/264 (42.8)
 VA 63/286 (22.0) 44/264 (16.7)
 Basilar 69/286 (24.1) 43/264 (16.3)
 Multiple 24/286 (8.4) 10/264 (3.8) 0.0001
% stenosis± 63.6 (16.9) 63.5 (15.5) 0.9595
Baseline Laboratory Values
 SBP± 139.9 (16.6) 139.8 (17.6) 0.9144
 DBP± 76.5 (10.2) 77.2 (10.5) 0.3892
 HbA1c± 7.4 (2.0) 8.1 (2.5) 0.0555
 HDL± 44.5 (12.6) 44.1 (14.1) 0.7267
 LDL± 119.4 (39.8) 127.7 (36.3) 0.0183
±

data represented in mean (standard deviation)